Clinicopathologic analysis of 66 Japanese thin melanomas with metastasis of sentinel or regional lymph node

Journal of Cutaneous Pathology

Volumn 40, Issue 12, 2013, Pages 1027-1034

  Mori, Mayumi ^a   Sugiura, Mitsuhiro ^a,b   Kono, Michihiro ^a   Matsumoto, Takaaki ^a   Sawada, Masaki ^a   Yokota, Kenji ^a   Yasue, Satoshi ^a   Shibata, Shinichi ^a   Sakakibara, Akihiro ^a   Nakamura, Shigeo ^a   Tomita, Yasushi ^a   Akiyama, Masashi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOSEI GENERAL HOSPITAL   (Japan)

Author keywords

dermatopathology; immunohistochemical method; melanoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CD8+ T LYMPHOCYTE; FEMALE; HUMAN; IMMUNOHISTOCHEMICAL METHOD; LYMPH NODE METASTASIS; MALE; MELANOMA; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SKIN DISEASE; SKIN TUMOR; VERY ELDERLY;

DERMATOPATHOLOGY; IMMUNOHISTOCHEMICAL METHOD; MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 84888639039     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12222     Document Type: Article

References (28)

1. Warycha MA, Zakrzewski J, Ni Q, et al. Meta-analysis of sentinel lymph node positivity in thin melanoma(≤1 mm). Cancer 2009; 115: 869.
2. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635.
3. Bleicher RJ, Essner R, Foshag LJ, Wanek LA, Morton DL,. Role of sentinel lymphadenectomy in thin invasive cutaneous melamomas. J Clin Oncol 2003; 21: 1326.
4. Nahabedian MY, Tufaro AP, Manson PN,. Sentinel lymph node biopsy for the T1(thin) melanoma: Is it necessary? Ann Plast Surg 2003; 50: 601.
5. Frahm SO, Schubert C, Parwaresch R, Rudolph P,. High proliferative activity may predict early metastasis of thin melanomas. Hum Pathol 2001; 32: 1376.
6. Pontikes LA, Temple WJ, Cassar SL, et al. Influence of level and depth on recurrence rate in thin melanomas. Am J Surg 1993; 165: 225.
7. Büttner P, Garbe C, Bertz J, et al. Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer 1995; 75: 2499.
8. McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol 2001; 19: 2851.
9. Tsutsumida A, Furukawa H, Yamamoto Y, et al. Sentinel node biopsy versus elective lymph node dissection in patients with cutaneous melanoma in a Japanese population. Int J Clin Oncol 2007; 12: 245.
10. Tsutsumida A, Furukawa H, Hata S, Saito A, Yamamoto Y,. Prediction of metastases in melanoma patients with positive sentinel node: histological and molecular approach. J Dermatol 2007; 34: 31.
11. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199.
12. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A 3rd, (eds). AJCC Cancer Staging Manual, 7th ed. New York: Springer, 2009; 325.
13. Clark WH Jr, Elder DE, Guerry D 4th, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 81: 1893.
14. Nakano J, Muto M, Shimizu T, Hirota T, Ichimiya M, Asagami C,. Ganglioside expression in melanomas from Japanese individuals: unusual pattern in two patients with metastatic lesions of acral lentiginous melanomas. Pigment Cell Res 1997; 10: 201.
15. Woods JE, Soule EH, Creagan ET,. Metastasis and death in patients with thin melanomas (less than 0.76 mm). Ann Surg 1983; 198: 63.
16. Slingluff CL Jr, Vollmer RT, Reintgen DS, Seigler HF,. Lethal "thin" malignant melanoma. Identifying patients at risk. Ann Surg 1988; 208: 150.
17. Wong SL, Brady MS, Busam KJ, Coit DG,. Results: of sentinel lymph node biopsy in patients with thin melanoma. Ann Surg Oncol 2006; 13: 302.
18. Kesmodel SB, Karakousis GC, Botbyl JD, et al. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol 2005; 12: 1.
19. Ra JH, McMasters KM, Spitz FR,. Should all melanoma patients undergo sentinel lymph node biopsy? Curr Opin Oncol 2006; 18: 185.
20. Thompson JF, Shaw HM,. Is sentinel lymph node biopsy appropriate in patients with thin melanomas: too early to tell? Ann Surg Oncol 2006; 13: 279.
21. Mansson-Brahme E, Carstensen J, Erhardt K, Lagerlöf B, Ringborg U, Rutqvist LE,. Prognostic factors in thin cutaneous malignant melanoma. Cancer 1994; 73: 2324.
22. Wagner JD, Gordon MS, Chuang TY, et al. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer 2000; 89: 453.
23. Schmid-Wendtner MH, Baumert J, Schmidt M, Plewig G, Volkenandt M, Hölzel D,. Prognostic index for cutaneous melanoma: an analysis after follow-up of 2715 patients. Melanoma Res 2001; 11: 619.
24. Azzola MF, Shaw HM, Thompson JF, et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center. Cancer 2003; 97: 1488.
25. Ranieri JM, Wagner JD, Wenck S, Johnson CS, Coleman JJ 3rd., The prognostic importance of sentinel lymph node biopsy in thin melanoma. Ann Surg Oncol 2006; 13: 927.
26. Scolyer RA, Thompson JF, Shaw HM, McCarthy SW,. The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma. J Cutan Pathol 2006; 33: 395.
27. Gimotty PA, Elder DE, Franker DL, et al. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. J Clin Oncol 2007; 25: 1129.
28. Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N,. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996; 77: 1303.